FDA Recall Terminated

Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.

Recall: Z-1338-2019 · Initiated March 31, 2019

Recall

Recall Number
Z-1338-2019
Event Number
82653
Firm
Integra Limited
FEI Number
3001700044
Product Code
KGN
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
March 31, 2019
Terminated
May 7, 2020
Address
311 Enterprise Dr, Plainsboro, NJ, 08536-3344

Description

Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.

Reason

Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months

Action

Integra Lifesciences notified consignees (Hospitals, Distributors and Sales reps) by letter delivered by courier service, facsimile or email on April 1st, 2019. Letter identifies problems, health risk and action to take: review inventory, immediately stop use and return product and complete the Acknowledgment form. Questions Contact Customer Service at 1-800-654-2873 Monday to Friday 8:00 AM 8:00 PM EST or [email protected].

Distribution

Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil

Quantity

274 units